Telephone
61.3.9209.9688
Address
Unit 1 31 Sabre Drive Port Melbourne, Victoria (VIC) 3207
Description
Austco Healthcare Ltd. engages in the development, manufacture, and supply of hardware relating to healthcare and electronic communications systems. It operates through the following geographical segments: Australia/New Zealand, Asia, Europe, and North America. The company was founded by Robert Edward Grey in 2004 and is headquartered in Port Melbourne, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.11 - 0.2
Trade Value (12mth)
AU$3,110.00
1 week
0%
1 month
2.7%
YTD
58.33%
1 year
52%
All time high
0.795779
EPS 3 yr Growth
-18.700%
EBITDA Margin
8.40%
Operating Cashflow
$0m
Free Cash Flow Return
1.30%
ROIC
9.30%
Interest Coverage
51.80
Quick Ratio
1.50
Shares on Issue (Fully Dilluted)
296m
HALO Sector
Industrials
Next Company Report Date
22-Aug-24
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
30 September 22 |
Update - Dividend/Distribution - AHC
×
Update - Dividend/Distribution - AHC |
30 November 22 |
Notification of cessation of securities - AHC
×
Notification of cessation of securities - AHC |
29 November 23 |
Application for quotation of securities - AHC
×
Application for quotation of securities - AHC |
29 May 23 |
Austco to acquire Healthcare & Communications Business
×
Austco to acquire Healthcare & Communications Business |
28 September 23 |
Notice of Annual General Meeting
×
Notice of Annual General Meeting |
28 September 23 |
Austco Healthcare Proxy Form and Access Letter
×
Austco Healthcare Proxy Form and Access Letter |
28 September 22 |
Annual Report to shareholders
×
Annual Report to shareholders |
28 November 22 |
Chairman's Address to Shareholders
×
Chairman's Address to Shareholders |
28 November 22 |
CEO's Address to Shareholders
×
CEO's Address to Shareholders |
28 November 22 |
Results of Meeting
×
Results of Meeting |
27 September 23 |
Notification regarding unquoted securities - AHC
×
Notification regarding unquoted securities - AHC |
27 September 23 |
Issue of Performance Rights
×
Issue of Performance Rights |
27 October 22 |
Notice of Annual General Meeting/Proxy Form
×
Notice of Annual General Meeting/Proxy Form |
27 November 23 |
Teknocorp acquisition completion
×
Teknocorp acquisition completion |
27 November 23 |
Proposed issue of securities - AHC
×
Proposed issue of securities - AHC |
26 September 22 |
Notification of cessation of securities - AHC
×
Notification of cessation of securities - AHC |
25 September 23 |
Acquisition agreement for Teknocorp executed
×
Acquisition agreement for Teknocorp executed |
25 January 22 |
Austco Healthcare expects improved profit for 1HFY22
×
Austco Healthcare expects improved profit for 1HFY22 |
25 August 22 |
Appendix 4E & FY22 Financial Statements
×
Appendix 4E & FY22 Financial Statements |
25 August 22 |
Austco FY22 Results Release
×
Austco FY22 Results Release |
25 August 22 |
Dividend/Distribution - AHC
×
Dividend/Distribution - AHC |
25 August 22 |
Dividend Reinvestment Plan
×
Dividend Reinvestment Plan |
25 August 22 |
Appendix 4G and Corporate Governance Statement
×
Appendix 4G and Corporate Governance Statement |
24 February 22 |
Austco Healthcare Appendix 4D and Interim Financial Report
×
Austco Healthcare Appendix 4D and Interim Financial Report |
24 February 22 |
Austco Healthcare HY Dec 21 Results and Media Release
×
Austco Healthcare HY Dec 21 Results and Media Release |
24 August 23 |
Appendix 4E & FY23 Financial Statements
×
Appendix 4E & FY23 Financial Statements |
24 August 23 |
Austco FY23 Results Media Release
×
Austco FY23 Results Media Release |
24 August 23 |
Appendix 4G and Corporate Governance Statement
×
Appendix 4G and Corporate Governance Statement |
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.